BAZ2A

BAZ2A (TIP5) is a multi-domain chromatin scaffold that represses transcription at both ribosomal DNA and protein-coding gene loci by integrating histone-mark recognition, nucleic acid binding, and recruitment of chromatin-modifying effectors. Its PHD finger binds unmodified histone H3 tails while its bromodomain recognizes H3K14ac and H4 acetylation marks through a KacXXR motif, together enabling nucleosome-specific recruitment of the NoRC remodeling complex (PMID:25533489, PMID:25799074); its TAM domain adopts an MBD-like fold with a unique RNA-binding surface that binds dsDNA and dsRNA in a sequence-nonspecific manner, targeting BAZ2A to specific genomic loci via noncoding RNA and mediating interactions with TOP2A and KDM1A to repress genes at inactive enhancers (PMID:25916849, PMID:34715126, PMID:37184661). Beyond individual loci, BAZ2A partners with SNF2H, TOP2A, and cohesin on chromatin to regulate three-dimensional genome compartmentalization, where its loss increases chromatin accessibility at B compartments and expands active A domains in a TOP2A-dependent manner (PMID:33433018). BAZ2A also interacts with EZH2 to maintain epigenetic silencing of metastasis-associated genes in prostate cancer, and its bromodomain-H3K14ac interaction sustains cancer stem cell properties (PMID:25485837, PMID:34403195).

1. 2005 Medium

   Establishing that TIP5-family proteins serve as scaffolds within ISWI chromatin-remodeling complexes: the Drosophila ortholog Toutatis was shown to physically interact with ISWI, the GATA factor Pannier, and the LIM-domain cofactor Chip to regulate proneural gene expression, demonstrating an evolutionarily conserved role in assembling chromatin remodeling machinery.

   Evidence Yeast two-hybrid, co-immunoprecipitation, and genetic epistasis in Drosophila

   PMID:16141224

   Open questions at the time

   • Drosophila ortholog — relevance to mammalian BAZ2A not directly tested
   • ISWI interaction not structurally mapped
   • no direct demonstration in rDNA silencing context
2. 2013 Medium

   Mapping BAZ2A domain requirements for subnuclear targeting revealed that the TAM domain mediates nucleolar localization and nuclear matrix association, while AT-hooks are independently needed for nucleolar targeting, establishing how BAZ2A organizes large-scale rDNA chromatin architecture.

   Evidence Domain deletion/overexpression, nuclear matrix fractionation, and DNase I accessibility assays in mammalian cells

   PMID:23580549

   Open questions at the time

   • Overexpression-based — physiological relevance of nuclear matrix association unclear
   • mechanism linking nuclear matrix targeting to transcriptional silencing not defined
3. 2013 Medium

   Upstream regulation of BAZ2A was defined when the NuRD complex was found to directly bind the TIP5 promoter, repressing its expression and thereby controlling DNMT recruitment and rDNA promoter methylation — establishing BAZ2A as a regulated node in epigenetic cascades.

   Evidence ChIP on TIP5 promoter, NuRD component knockdown with DNA methylation analysis

   PMID:23796711

   Open questions at the time

   • Single study — no independent replication
   • NuRD–TIP5 promoter interaction not mapped to specific NuRD subunits
4. 2014 Medium

   BAZ2A was shown to regulate protein-coding genes beyond rDNA, interacting with EZH2 to maintain epigenetic silencing of metastasis-associated genes in prostate cancer, broadening its functional scope from rDNA silencer to a general transcriptional repressor.

   Evidence Co-immunoprecipitation of BAZ2A–EZH2; loss-of-function with gene expression profiling in prostate cancer cells

   PMID:25485837

   Open questions at the time

   • BAZ2A–EZH2 interaction domain not mapped
   • whether BAZ2A directly recruits PRC2 or acts indirectly not resolved
5. 2014 High

   Structural resolution of the BAZ2A reader domains showed that the PHD finger recognizes unmodified H3 and the bromodomain binds acetylated H3/H4 via a KacXXR motif, enabling trans-histone-tail recognition critical for NoRC recruitment to nucleosomes.

   Evidence Crystal structures of PHD–H3 and BRD–acetylated peptide complexes; SAXS of PHD-BRD module

   PMID:25533489

   Open questions at the time

   • No full-length BAZ2A structure
   • contribution of each reader domain to chromatin targeting in vivo not separately quantified
6. 2015 High

   Structural and cellular studies confirmed canonical acetyl-lysine competitive binding by the BAZ2A bromodomain and demonstrated that chemical probes (GSK2801) can displace BAZ2A from acetylated chromatin in living cells, validating the bromodomain as a druggable chromatin-reading module.

   Evidence Crystal structures of BRD–inhibitor complexes; FRAP displacement assays; competition binding (KD = 257 nM)

   PMID:25719566 PMID:25799074

   Open questions at the time

   • Functional consequences of bromodomain inhibition on gene expression not fully explored at this stage
   • selectivity over other bromodomains not comprehensively benchmarked
7. 2015 High

   The TAM domain was structurally defined as an MBD-like fold with C-terminal extensions forming a unique RNA-binding surface; mutations in this surface abolished RNA binding in vitro and in vivo, establishing the molecular basis for noncoding RNA-mediated NoRC targeting to genomic loci.

   Evidence NMR structure; RNA-binding mutagenesis with in vitro and in vivo assays

   PMID:25916849

   Open questions at the time

   • Identity of specific targeting RNAs beyond pRNA not comprehensively catalogued
   • whether RNA binding is sufficient for locus-specific recruitment not tested
8. 2020 High

   BAZ2A was found to regulate three-dimensional genome organization by interacting with SNF2H, TOP2A, and cohesin on ESC chromatin; its depletion increased accessibility at B compartments and expanded A compartments, establishing BAZ2A as a regulator of higher-order chromatin architecture beyond individual gene silencing.

   Evidence Co-immunoprecipitation, Hi-C, ATAC-seq, ChIP-seq upon BAZ2A depletion in mouse ESCs

   PMID:33433018

   Open questions at the time

   • Whether genome compartment changes are direct or secondary to altered gene expression
   • structural basis of BAZ2A–cohesin or BAZ2A–SNF2H interaction unknown
9. 2021 Medium

   The bromodomain was shown to specifically read H3K14ac at inactive enhancers to mediate BAZ2A association with these regions; disruption of this interaction impaired prostate cancer stem cell features, linking the bromodomain reader function to cancer stem cell maintenance.

   Evidence ChIP-seq of BAZ2A and H3K14ac; BRD point mutations and pharmacological inhibition; prostate organoid transformation assays

   PMID:34403195

   Open questions at the time

   • Whether EP300-mediated H3K14ac is sufficient for BAZ2A recruitment not directly tested by EP300 depletion
   • inactive enhancer definition relies on specific chromatin state criteria that may vary across cell types
10. 2021 High

    Crystallographic and biophysical studies established that the TAM domain binds both dsDNA and dsRNA in a sequence-nonspecific, backbone-contact manner distinct from canonical MBD methylation-dependent reading, resolving a longstanding question about why the TAM domain does not function as a methyl-CpG reader despite its MBD fold.

    Evidence X-ray crystallography of TAM–nucleic acid complexes; ITC; EMSAs; mutagenesis

    PMID:34715126

    Open questions at the time

    • How sequence-nonspecific binding achieves locus-specific targeting in vivo remains unresolved
    • relative contributions of DNA vs. RNA binding to BAZ2A function not dissected
11. 2023 Medium

    An RNA-dependent repressive mechanism distinct from rDNA silencing was uncovered: the TAM domain mediates interactions with TOP2A and KDM1A at protein-coding gene loci, and pharmacological inhibition of either enzyme de-represses BAZ2A target genes at inactive enhancers without affecting rRNA genes.

    Evidence Co-immunoprecipitation; ChIP-seq; pharmacological inhibition of TOP2A (etoposide) and KDM1A; TAM domain mutations in prostate cancer cells

    PMID:37184661

    Open questions at the time

    • Whether TAM–TOP2A and TAM–KDM1A interactions are direct or RNA-bridged not fully resolved
    • the identity of specific RNAs bridging these interactions is unknown
    • single cancer cell system — generalizability not tested

• Key unresolved questions include: (1) the full-length structure of BAZ2A and how its multiple domains are coordinated on nucleosomes; (2) the identity and specificity of RNA species that target BAZ2A to protein-coding gene loci; and (3) how BAZ2A's repressive activity at inactive enhancers is coordinated with its role in 3D genome compartmentalization.
• No full-length BAZ2A structure available
• RNA partners beyond pRNA not systematically identified
• mechanistic relationship between enhancer-level silencing and compartment-level genome organization unresolved